Chordate Medical Holding AB (publ) (STO:CMH.PREF)

Market Cap	17.06M
Revenue (ttm)	2.41M
Net Income (ttm)	-26.99M
Shares Out	n/a
EPS (ttm)	-20.47
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	50
Average Volume	1,543
Open	3.780
Previous Close	3.720
Day's Range	3.780 - 3.780
52-Week Range	2.500 - 6.000
Beta	n/a
RSI	49.73
Earnings Date	Aug 29, 2025

About STO:CMH.PREF

Chordate Medical Holding AB (publ), a medical technology company, engages in the development of products and solutions for neurostimulation treatment in Sweden. It offers Ozilia, a neuromodulation and medication-free treatment technology for chronic migraine and chronic rhinitis. The company was founded in 2005 and is based in Kista, Sweden.

• Industry: Electromedical and Electrotherapeutic Apparatus
• Founded: 2005
• Employees: 3
• Stock Exchange: Nasdaq Stockholm
• Ticker Symbol: CMH.PREF

Financial Performance

In 2024, STO:CMH.PREF's revenue was 2.44 million, an increase of 39.85% compared to the previous year's 1.75 million. Losses were -27.25 million, -6.62% less than in 2023.